Celldex Therapeutics Inc
(NAS:CLDX)
$
36.92
0.6 (1.65%)
Market Cap: 2.43 Bil
Enterprise Value: 1.61 Bil
PE Ratio: 0
PB Ratio: 2.90
GF Score: 62/100 Celldex Therapeutics Inc to Discuss the CDX-0159 Phase 1b Study Results in Cold Urticaria and Symptomatic Dermographism Late Breaking Presentation at EAACI 2021 - Conference Call Transcript
Jul 12, 2021 / 12:15PM GMT
Release Date Price:
$40.67
(+25.49%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot